- Oregon-based
Kirkman Group is FDA-licensed and cGMP-certified
- The
acquisition, part of Hemptown’s vertical integration strategy, will enable
the company to make its immediate entry into the consumer packaged goods
field
- The
company has already acquired and planted 4.5 million hemp seeds in plots
across three states
- Forecast
high yields and the latest acquisition are expected to enable Hemptown USA
to position itself as a leader in the rapidly expanding cannabinoid
product market
Hemptown
USA, a privately held company headquartered in Southern Oregon’s Emerald
Triangle, is currently focusing on its rapid, vertically integrated growth
within the lucrative cannabis industry. As a part of this strategy, the company
announced the acquisition of assets comprising the FDA licensed, cGMP-certified
operating nutraceutical business of the Kirkman Group (http://ibn.fm/GaNUI).
Based in Lake Oswego, Oregon, Kirkman Group has finalized a
transaction with Hemptown USA that encompasses the company’s management team,
formulations, production equipment, proprietary intellectual property and current
sale channels, among others. Kirkman’s former owner and chairman, David
Humphrey, will remain with Kirkman, offering guidance in a role that’s yet to
be determined.
The Kirkman Group’s 25,000-square-foot nutraceutical
facility is fully operational and comprised of innovative equipment and
formulations aimed at facilitating precision dosage of cannabidiol (CBD) and
cannabigerol (CBG) product formulations, including tinctures, gel caps, topical
products and edibles.
For over 70 years, the company has been supplying
world-class formulations for children with autism. Currently, Kirkman produces
$6 million in annual revenue, and forecasts suggest growth in the future.
This acquisition enables the completion of Hemptown USA’s
vertical integration plans. In addition, it facilitates the company’s immediate
entry into the consumer packaged goods field.
To ensure its stability and growth in the future, Hemptown
USA is positioning itself as one of the prominent CBG manufacturers in the U.S.
CBG, a type of cannabinoid that’s less commonly produced than CBD, is often
called the “mother of all cannabinoids.” It is a precursor to other cannabinoid
compounds, and studies suggest that it has immense health benefits.
In the spring of 2019, Hemptown USA acquired 4.5 million
rare hemp seeds. These have been divided three ways – one third went to
Kentucky, another third was planted in Colorado and the final third (all CBG
genetics) remained in Oregon. The seeds were planted in greenhouses to begin
with, and, in mid-summer, they were taken outdoors and planted on over 1500
acres of land in the three states.
Based on its crop production efforts and the acquisition of
the Kirkman Group production facility, Hemptown USA can fast track
formulations, product development and subsequent distribution.
Hemptown USA is already recognized for growing some of the
finest hemp plants in the world. Following a successful first-year yield,
Hemptown USA is currently working to scale up operations and benefit from the
growing global demand for high quality cannabinoid products.
Having farmland in three states, as well in-house extraction
facilities, enables Hemptown USA to vertically integrate the consumer packaged
goods sector with top-quality branded lines for the consumer market. All of
these steps and strategic decisions are expected to enable Hemptown USA to
capitalize on a market that’s forecast to reach $22 billion by 2020.
Check out http://ibn.fm/fTpMc for
a brief video on recent developments.
For more information, visit the company’s website at www.HemptownUSA.com
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment